Showing results (161-170 of 226) with videos related to
Sort By:
Pageof 23
Brain Research|December 10, 1993
Effects of exposure to an estrous female on forebrain monoaminergic neurotransmission in the non-copulating male ratJ Vega-Matuszczyk, V Hillegaart, K Larsson, et al.Journal of Neural Transmission|January 1, 1987
Partial protection against hyperbaric oxygen induced convulsions by dopaminergic agents in mice: possible involvement of autoreceptors?C O Criborn, C Henriksson, S Ahlenius, et al.Neuroreport|June 19, 1995
Suggestive evidence for a DA D3 receptor-mediated increase in the release of oxytocin in the male ratK Uvnäs-Moberg, P Alster, V Hillegaart, et al.Pharmacology, Biochemistry, and Behavior|September 1, 1994
High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male ratsK Uvnäs-Moberg, S Ahlenius, V Hillegaart, et al.Pharmacology & Toxicology|April 1, 1991
Behavioural and biochemical effects of subchronic treatment with raclopride in the rat: tolerance and brain monoamine receptor sensitivityS Ahlenius, E L Ericson, K Högberg, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1998
Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated ratsP Salmi, K Malmgren, T H Svensson, et al.Journal of Medicinal Chemistry|September 27, 1996
Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptorsB B Höök, L Cortizo, A M Johansson, et al.Pharmacology & Toxicology|March 17, 2000
Pharmacological characterisation of the enantiomers of BM-5, a muscarinic partial agonist with opposed enantioselectivity between affinity and efficacyS Sundquist, A R Modiri, B M Nilsson, et al.Journal of Medicinal Chemistry|April 1, 1987
Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonistsA M Johansson, L E Arvidsson, U Hacksell, et al.Journal of Medicinal Chemistry|October 1, 1990
Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralinA M Johansson, K Fredriksson, U Hacksell, et al.Pageof 23